As the wave of lawsuits involving antipsychotic drug Risperdal continues to gain momentum, several key cases are slated for trial in the coming months in Pennsylvania state court. These suits involve allegations made on behalf of males who suffered excessive breast development after taking the medication in their youth. Johnson &... Read more »

According to the findings of a new study, published by the Journal of Clinical Psychopharmacology, the powerful antipsychotic drug Risperdal shows a positive correlation to the development of abnormal breast tissue in men – a condition known as gynecomastia. The study specifically concluded that the risk of gynecomastia extends not... Read more »

The atypical antipsychotic Risperdal continues to fuel litigation, as scores of male patients claim they developed breasts after taking the drug as children and adolescents. Court dockets indicate some 500 Risperdal lawsuits pending against pharmaceutical giant Johnson & Johnson, which has already settled a handful of claims (under confidential terms)... Read more »